Dr. John Sy, M.D

NPI: 1639435738
Total Payments
$1,342
2024 Payments
$306.44
Companies
11
Transactions
28
Medicare Patients
518
Medicare Billing
$209,545

Payment Breakdown by Category

Food & Beverage$1,185 (88.3%)
Education$157.00 (11.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,185 23 88.3%
Education $157.00 5 11.7%

Top Paying Companies

Company Total Records Latest Year
Fresenius USA Marketing, Inc. $461.53 7 $0 (2024)
Otsuka America Pharmaceutical, Inc. $292.26 6 $0 (2023)
Astellas Pharma US Inc $124.55 1 $0 (2017)
AKEBIA THERAPEUTICS INC $122.91 1 $0 (2019)
Novartis Pharmaceuticals Corporation $67.04 2 $0 (2024)
Aurinia Pharma U.S., Inc. $57.38 2 $0 (2024)
CALLIDITAS THERAPEUTICS US INC. $56.48 3 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $54.09 2 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $46.80 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $29.70 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $306.44 11 Novartis Pharmaceuticals Corporation ($67.04)
2023 $61.71 3 Calliditas Therapeutics US Inc. ($34.71)
2022 $36.20 2 Otsuka America Pharmaceutical, Inc. ($23.46)
2020 $143.40 4 Otsuka America Pharmaceutical, Inc. ($118.60)
2019 $423.16 4 Fresenius USA Marketing, Inc. ($300.25)
2018 $246.19 3 Otsuka America Pharmaceutical, Inc. ($123.20)
2017 $124.55 1 Astellas Pharma US Inc ($124.55)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/06/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $28.91 General
Category: Cardio-renal
10/08/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $34.15 General
10/01/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $21.77 General
Category: Nephrology
09/10/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $29.18 General
Category: LUPUS NEPHRITIS
07/30/2024 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $25.55 General
Category: Phosphate binder for ESRD
07/16/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $14.80 General
Category: DIABETES
06/25/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $28.20 General
Category: LUPUS NEPHRITIS
05/27/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $29.29 General
Category: NEPHROLOGY
05/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $32.00 General
Category: DIABETES
04/23/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $29.70 General
Category: Cardiovascular and Metabolism
03/12/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $32.89 General
11/28/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Education Cash or cash equivalent $13.60 General
Category: Nephrology
11/21/2023 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $27.00 General
Category: NEPHROLOGY
09/12/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Food and Beverage In-kind items and services $21.11 General
Category: Nephrology
09/15/2022 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $12.74 General
Category: Phosphate binder for ESRD
02/08/2022 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $23.46 General
Category: NEPHROLOGY
09/21/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. JYNARQUE (Drug) Education In-kind items and services $24.80 General
Category: NEPHROLOGY
09/17/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Education In-kind items and services $18.80 General
Category: NEPHROLOGY
09/17/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Education In-kind items and services $4.29 General
Category: NEPHROLOGY
08/31/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Education In-kind items and services $95.51 General
Category: NEPHROLOGY
11/19/2019 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $55.80 General
Category: Phosphate binder for ESRD
09/17/2019 Fresenius USA Marketing, Inc. Food and Beverage In-kind items and services $123.38 General
03/07/2019 AKEBIA THERAPEUTICS INC AURYXIA (Drug) Food and Beverage In-kind items and services $122.91 General
Category: NEPHROLOGY
01/10/2019 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $121.07 General
Category: Phosphate binder for ESRD
12/05/2018 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $123.20 General
Category: NEPHROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 407 911 $592,306 $120,456
2022 3 67 260 $243,274 $47,505
2021 3 44 163 $192,736 $41,583
Total Patients
518
Total Services
1,334
Medicare Billing
$209,545
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 110 456 $207,024 $46,521 22.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 22 118 $183,962 $35,583 19.3%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 16 44 $56,892 $11,165 19.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 109 129 $55,470 $10,766 19.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 79 86 $51,342 $9,580 18.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 32 32 $20,848 $3,653 17.5%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 19 24 $10,344 $2,000 19.3%
99442 Telephone medical discussion with physician, 11-20 minutes Facility 2023 20 22 $6,424 $1,189 18.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 15 86 $134,074 $26,330 19.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 36 138 $62,652 $11,982 19.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 16 36 $46,548 $9,193 19.7%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 18 95 $136,783 $29,783 21.8%
90961 Dialysis services (2-3 physician visits per month), patient 20 years of age and older Office 2021 14 35 $40,971 $8,854 21.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 12 33 $14,982 $2,947 19.7%

About Dr. John Sy, M.D

Dr. John Sy, M.D is a Nephrology healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1639435738.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sy, M.D has received a total of $1,342 in payments from pharmaceutical and medical device companies, with $306.44 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,185).

As a Medicare-enrolled provider, Sy has provided services to 518 Medicare beneficiaries, totaling 1,334 services with total Medicare billing of $209,545. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Long Beach, CA
  • Active Since 04/03/2012
  • Last Updated 06/21/2018
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1639435738

Products in Payments

  • JYNARQUE (Drug) $346.35
  • Velphoro (Drug) $335.21
  • Astagraf XL (Drug) $124.55
  • AURYXIA (Drug) $122.91
  • LUPKYNIS (Drug) $57.38
  • TARPEYO (Drug) $56.48
  • JARDIANCE (Drug) $46.80
  • LOKELMA (Drug) $29.70
  • Kerendia (Drug) $28.91
  • Cyclers (Device) $2.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Long Beach